December 13, 2013 by Chain Drug Review
Issue 12-16-2013, News
TORONTO — Shoppers Drug Mart has revamped its Life Brand line of vitamins and supplements and launched an online tool to help customers find health products. Executives explain that the online tool — the Life Brand Vitamin Finder — gives consumers round-the-clock access to a wealth of information about the growing range of vitamins, minerals,
December 13, 2013 by Chain Drug Review
Issue 12-16-2013, News
SEATTLE — Bartell Drugs is testing a state-of-the-art system that will let its customers print anything from a personal photo book to a classic novel in just minutes. The full-service digital-to-print media center features On Demand Books’ in-store Espresso Book Machine integrated with Kodak Picture Kiosks. It is being introduced at Bartell’s University Village store
December 13, 2013 by Chain Drug Review
Issue 12-16-2013, News
WOONSOCKET, R.I. — CVS Caremark Corp. has named longtime health care industry veteran Tracy Bahl executive vice president of health plans. He will oversee the company’s teams that support its health plan clients and help them navigate the nation’s evolving health care system. Bahl joins CVS Caremark after nearly three decades as a health care
December 13, 2013 by Chain Drug Review
Issue 12-16-2013, News
BALTIMORE — With the opening of a new store here in collaboration with Johns Hopkins Medicine (JHM), Walgreen Co. has re-emphasized the role of retail pharmacy in bringing new health and wellness services to communities, reinforced the benefits of pharmacy working with other health care providers to improve outcomes and lower costs and helped to
December 13, 2013 by Chain Drug Review
Issue 12-16-2013, Opinion
It’s not that Mark Cosby, the departing president of the CVS drug chain, was not respected. After all, here was an executive with an extensive retailing background, most notably at Sears and Macy’s. The drawback was that Cosby was not a chain drug retailer. As such, he lacked several of the requisites for leadership in
December 13, 2013 by Chain Drug Review
Issue 12-16-2013, Opinion
While the new regulations governing pharmacy compounding contained in the Drug Quality and Security Act, which received final congressional approval and was signed into law by President Obama last month, garnered most of the media attention, the bigger story is the provisions of the legislation giving the Food and Drug Administration the authority to create